Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-194"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20100922.20.3-194"2
lpv:hasSubsequent	lp_eu:2010-09-22-Speech-3-9752
lpv:speaker	lp:Vito Bonsignore2
lpv:spokenAs	member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2010-03-10--2014-06-30)3 substitute; Special committee on the policy challenges and budgetary resources for a sustainable European Union after 2013 (2010-06-17--2011-06-30)3 unknown; Il Popolo della Libertà (2009-07-14--2014-01-22)3 member; Special Committee on the Financial, Economic and Social Crisis (2009-10-08--2011-07-31)3 substitute; BUDG (2009-07-16--2012-01-18)3 vice-chair; EPP (2009-07-14--2014-06-30)3 substitute; PECH (2010-03-10--2012-01-18)3 substitute; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 member; Delegation for relations with the Mashreq countries (2009-09-16--2014-06-30)3
lpv:translated text	"Through the measures voted on today, we will ensure greater protection for European patients, while guaranteeing them more analytical information about the undesirable effects of certain medicinal products. I am convinced that the establishment of a centralised database, connected to national databases, as envisaged by the rapporteur, represents an effective tool for ensuring that all European citizens are aware of any undesirable effects of medicinal products in use in the EU. The European Union has a responsibility to keep its citizens as informed as possible, including in the area of health: only in this way will they be able to make the best choices. I am likewise convinced that a sound pharmacovigilance policy is an effective tool for indirect prevention in avoiding cases of poisoning or incorrect consumption of medicinal products. In this regard, the black symbol with the wording ‘this medicinal product is subject to additional monitoring’ on those medicinal products which are subject to more thorough checks may actually ensure greater safety, as well as more accurate information for citizens. For these reasons, I voted in favour of both texts tabled by the rapporteur, Mrs McAvan."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph